Washington HCA UMP Pharmacy Benefit RFI — 2026HCA6
The Washington State Health Care Authority (HCA) released RFI 2026HCA6, UMP Pharmacy Benefit RFI, on September 8, 2026. HCA is gathering market information for consideration of a potential future procurement for the self-insured Uniform Medical Plan pharmacy benefit serving approximately 435,000 Public Employees Benefits Board and School Employees Benefits Board members.
Deadline and value
The controlling HCA RFI states that responses are due October 9, 2026. The exact clock time and time zone were not exposed in the accessible controlling HCA source during Atlas verification, so Atlas does not infer them. HCA’s competitive-solicitation notice lists the solicitation budget as N/A. This is a request for information, not a current grant award or contract award, so Atlas does not assign a contract value.
Who HCA wants to hear from
Washington’s Office of Minority and Women’s Business Enterprises, reproducing the state opportunity information and directing vendors to the official WEBS record, states that HCA seeks qualified pharmacy benefit managers (PBMs), pharmacy benefit administrators (PBAs), third-party administrators (TPAs), and related vendors with experience administering large, self-insured public-sector pharmacy benefit programs. It states that responses from other entities will not be reviewed.
Scope
HCA seeks information addressing pharmacy benefit design; administrative models including PBM, TPA, and hybrid approaches; cost containment; population-health strategies; alignment with the medical benefit; enhanced transparency, cost control, and innovation; and alternative financing approaches.
Submission and controls
The complete solicitation is listed in Washington’s WEBS vendor system under 2026HCA6. Potential respondents should review the complete RFI, the WEBS record, and all current amendments or Q&A before submitting. HCA procurement inquiries are directed through HCAProcurements@hca.wa.gov. Match and cost share are not applicable because this is an RFI rather than a grant.
Atlas assessment
Atlas Opportunity Score: 62/100. This is strategically important Washington healthcare procurement intelligence because it concerns a large public self-insured pharmacy benefit and could lead to a future competitive acquisition, but the current action is market research rather than an award.
N9+ Fit: 0/100. QC Healthcare Fit: 0/100. Dr. Miltie direct-response fit: 0/100. The respondent pool is focused on qualified pharmacy-benefit administration organizations with large public-sector self-insured experience. The controlling scope does not establish a remote physical examination, telehealth-device, RPM, or clinical-staffing role, and Atlas does not force such a fit.
Official sources
Washington State Health Care Authority — UMP Pharmacy Benefit RFI
Washington State Health Care Authority — Bids and contracts